Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD)

[1]  Angie A. Kehagia,et al.  Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease , 2010, The Lancet Neurology.

[2]  L Junck,et al.  Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes , 2010, Neurology.

[3]  Johannes C. Klein,et al.  Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo , 2010, Neurology.

[4]  F. Nobili,et al.  Cognitive‐nigrostriatal relationships in de novo, drug‐naïve Parkinson's disease patients: A [I‐123]FP‐CIT SPECT study , 2010, Movement disorders : official journal of the Movement Disorder Society.

[5]  N. Cairns,et al.  In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia , 2010, Neurology.

[6]  T. Suhara,et al.  Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET , 2009, Neuroscience Research.

[7]  Philippe Hantraye,et al.  Decrease of Nicotinic Receptors in the Nigrostriatal System in Parkinson's Disease , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  Albert Gjedde,et al.  Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson’s disease , 2009, NeuroImage.

[9]  Gianmario Sambuceti,et al.  Amnestic mild cognitive impairment in Parkinson's disease: A brain perfusion SPECT study , 2009, Movement disorders : official journal of the Movement Disorder Society.

[10]  Y. An,et al.  Changes in Cerebral Glucose Metabolism in Patients with Parkinson Disease with Dementia After Cholinesterase Inhibitor Therapy , 2008, Journal of Nuclear Medicine.

[11]  N. Sawamoto,et al.  Cognitive deficits and striato-frontal dopamine release in Parkinson's disease. , 2008, Brain : a journal of neurology.

[12]  Keith A. Johnson,et al.  Imaging amyloid deposition in Lewy body diseases , 2008, Neurology.

[13]  V. Dhawan,et al.  Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease , 2008, Neurology.

[14]  H. Shill,et al.  Defining mild cognitive impairment in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[15]  Piero Calvini,et al.  The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  David Eidelberg,et al.  Metabolic brain networks associated with cognitive function in Parkinson's disease , 2007, NeuroImage.

[17]  P. Nathan,et al.  Molecular Imaging of the Dopaminergic System and its Association with Human Cognitive Function , 2006, Biological Psychiatry.

[18]  M. Oda,et al.  Frontal Assessment Battery and Brain Perfusion Image in Parkinson’s Disease , 2006, Journal of geriatric psychiatry and neurology.

[19]  T. Robbins,et al.  Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson’s disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[20]  Juha O. Rinne,et al.  Cortical 6-[18F]fluoro-l-dopa uptake and frontal cognitive functions in early Parkinson's disease , 2005, Neurobiology of Aging.

[21]  L. Defebvre,et al.  Cognitive and SPECT characteristics predict progression of Parkinson’s disease in newly diagnosed patients , 2004, Journal of Neurology.

[22]  Patrick Santens,et al.  Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  Akinori Nakamura,et al.  Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies , 2004, NeuroImage.

[24]  N. Bohnen,et al.  Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. , 2003, Archives of neurology.

[25]  M. J Firbank,et al.  Regional cerebral blood flow in Parkinson's disease with and without dementia , 2003, NeuroImage.

[26]  Akinori Nakamura,et al.  Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study. , 2002, Brain : a journal of neurology.

[27]  R. Albin,et al.  Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  C. Nahmias,et al.  Dopamine visualized in the basal ganglia of living man , 1983, Nature.